Valneva Initiates Second Phase 2 Study for its Lyme Disease Vaccine Candidate VLA15

NEXT STORY
Beta Bionics Announces Closing of a $63 Million Series B2 Financing, Bringing the Total Series B and B2 Financings to $126 Million
PREV STORY
Cardiac Rhythm Management (CRM) Devices Market to Surpass US$ 19,938.3 Mn by 2026, Boston Scientific Corporation and Medtronic Covers Majority of the Share: Fortune Business Insights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Evoke Pharma’s Commercial Partner EVERSANA, Receives PM360’s Trailblazer Initiative Award for Innovation in Healthcare Marketing for GIMOTI

author_avatar
NASDAQ Market News

BridgeBio Pharma’s Phoenix Tissue Repair Provides Updates to its Recessive Dystrophic Epidermolysis Bullosa (RDEB) Program and Announces New Leadership Appointments

author_avatar
NASDAQ Market News

Worldwide Market for Emerging Medical Device Technologies to 2025 – Key Drivers and Restraints

author_avatar
NASDAQ Market News